申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04616009A1
公开(公告)日:1986-10-07
Indole-3-carboxamide derivatives of the formula: ##STR1## inclusive of pharmaceutically acceptable acid addition salt and/or hydrate forms thereof, wherein R.sup.1 is hydrogen, C.sub.1-4 alkyl, phenyl which may be optionally substituted by halogen on the benzene ring or phenyl-C.sub.1-4 alkyl which may be optionally substituted by halogen on the benzene ring; R.sup.2 is hydrogen or C.sub.1-4 alkyl; R.sup.3 is hydrogen, halogen, C.sub.1-4 alkyl, hydroxy or C.sub.1-4 alkoxy; R.sup.4 is hydrogen, C.sub.1-4 alkyl, C.sub.3-7 cycloalkyl, allyl or benzyl which may be optionally substituted by halogen on the benzene ring or by methyl on the .alpha.-carbon; R.sup.5 is hydrogen or C.sub.1-4 alkyl; m is 0 or 1; and n is an integer of 1 to 3, are useful as neuroleptic and anxiolytic drugs, and for the prevention and treatment of psychosomatic disturbances.
式子:##STR1## 包括其药学上可接受的酸盐和/或水合物形式,其中 R.sup.1 是氢,C.sub.1-4 烷基,苯基,其在苯环上可选择性地取代卤素或苯基-C.sub.1-4 烷基,其在苯环上可选择性地取代卤素;R.sup.2 是氢或C.sub.1-4 烷基;R.sup.3 是氢,卤素,C.sub.1-4 烷基,羟基或C.sub.1-4 烷氧基;R.sup.4 是氢,C.sub.1-4 烷基,C.sub.3-7 环烷基,烯丙基或苄基,其在苯环上可选择性地取代卤素,或在α-碳上取代甲基;R.sup.5 是氢或C.sub.1-4 烷基;m 为0或1;n 是1至3的整数,用作神经阻滞和抗焦虑药物,并用于预防和治疗心身疾病。